Status:
COMPLETED
Can the Number of Skin Tears be Reduced, by Prophylactic Treatment of the Skin in Dupuytrens Contracture Treated With Collagenase?
Lead Sponsor:
Zealand University Hospital
Conditions:
Dupuytren Disease of Finger
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
Collagenase has gained pace in treating Dupuytrens contracture for some years. Thus this treatment is performed routinely in many orthopaedic and or hand surgical department. One of these benefits of ...
Detailed Description
To the knowledge of the investigators no effective measures exists for preventing skin breakage following collagenase treatment of Dupuytrens disease. In the current study three different skin treatme...
Eligibility Criteria
Inclusion
- Dupuytrens contracture
- Extension deficit of 30 degrees or more in the metacarpophangeal joint or the proximal interphalangeal joint
Exclusion
- Previous treatment of the digit
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT07133945
Start Date
January 1 2018
End Date
June 30 2018
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zealand University Hospital
Køge, Region Sjælland, Denmark, 4600